PM
Pilavilai Mariadhas Anna
About Pilavilai Mariadhas Anna
Data last updated:
Pilavilai Mariadhas Anna is a Director at Beatpharma Laboratory Private Limited (since 2022) and Managing Director at Beatveins Laboratories Private Limited (since 2022). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹1.95 Cr; the largest is Beatpharma Laboratory Private Limited at ₹1.23 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Dec 2022 | 2022 | ₹1.23 Cr (FY 2023) | Active | |
| Managing Director | 24 Dec 2022 | 2022 | ₹72.5 Lakh (FY 2023) | Active |
Board colleagues of Pilavilai Mariadhas Anna
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dhanabalan Ganesan | 09835952 | Beatpharma Laboratory Private Limited , Beatveins Laboratories Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pilavilai Mariadhas Anna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pilavilai Mariadhas Anna
Pilavilai Mariadhas Anna currently holds 2 directorships: Beatpharma Laboratory Private Limited (Director, since 29 Dec 2022, revenue ₹1.23 Cr (FY 2023)); Beatveins Laboratories Private Limited (Managing Director, since 24 Dec 2022, revenue ₹72.5 Lakh (FY 2023)).
Pilavilai Mariadhas Anna was first appointed on 24 Dec 2022 as Managing Director at Beatveins Laboratories Private Limited.
The 2 current companies of Pilavilai Mariadhas Anna that report revenue have a combined latest revenue of ₹1.95 Cr: Beatpharma Laboratory Private Limited ₹1.23 Cr (FY 2023); Beatveins Laboratories Private Limited ₹72.5 Lakh (FY 2023).
The current boards of Pilavilai Mariadhas Anna's companies include Dhanabalan Ganesan (Beatpharma Laboratory Private Limited).